These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1576902)

  • 1. Advances in immunotherapy of sepsis.
    Klein DM; Witek-Janusek L
    Dimens Crit Care Nurs; 1992; 11(2):75-89. PubMed ID: 1576902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endotoxin, sepsis, and the primrose path.
    O'Reilly M; Newcomb DE; Remick D
    Shock; 1999 Dec; 12(6):411-20. PubMed ID: 10588508
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense?
    van der Poll T; Lowry SF
    Shock; 1995 Jan; 3(1):1-12. PubMed ID: 7850574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conventional supportive and possible future therapy in patients affected by GITS.
    Hodler J; Cottier H
    Curr Stud Hematol Blood Transfus; 1992; (59):241-300. PubMed ID: 1572216
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acute septic cardiomyopathy].
    Müller-Werdan U
    Internist (Berl); 1998 May; 39(5):467-78. PubMed ID: 9647981
    [No Abstract]   [Full Text] [Related]  

  • 6. Emerging therapies for sepsis and septic shock.
    Oh HM
    Ann Acad Med Singap; 1998 Sep; 27(5):738-43. PubMed ID: 9919353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic therapy for ARDS, septic shock, and multiple-organ failure.
    St John RC; Dorinsky PM
    Chest; 1993 Mar; 103(3):932-43. PubMed ID: 8449096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric septic shock and multiple organ failure.
    Carcillo JA
    Crit Care Clin; 2003 Jul; 19(3):413-40, viii. PubMed ID: 12848313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Pediatric Septic Shock With the Surviving Sepsis Campaign Guidelines and PICU Patient Outcomes.
    Workman JK; Ames SG; Reeder RW; Korgenski EK; Masotti SM; Bratton SL; Larsen GY
    Pediatr Crit Care Med; 2016 Oct; 17(10):e451-e458. PubMed ID: 27500722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential strategies for inflammatory mediator manipulation: retrospect and prospect.
    Fisher CJ; Zheng Y
    World J Surg; 1996 May; 20(4):447-53. PubMed ID: 8662133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunotherapy of sepsis and septic shock].
    Ivanović D; Gjurasin M; Gasparović V; Radonić R; Kvarantan M; Merkler M
    Lijec Vjesn; 1995 Jun; 117 Suppl 2():8-11. PubMed ID: 8649167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunotherapy in sepsis syndrome].
    Schellekens JF; van Deventer SJ
    Ned Tijdschr Geneeskd; 1992 May; 136(22):1050-4. PubMed ID: 1603159
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of anti-TNF-alpha treatment in an antibiotic treated murine model of shock due to Streptococcus pyogenes.
    Martin RA; Silva AT; Cohen J
    FEMS Microbiol Lett; 1993 Jun; 110(2):175-8. PubMed ID: 8349091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sepsis and septic shock.
    Ellrodt AG
    Emerg Med Clin North Am; 1986 Nov; 4(4):809-40. PubMed ID: 3536440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular dysfunction in human septic shock and endotoxemia.
    Parrillo JE
    Prog Clin Biol Res; 1989; 299():107-13. PubMed ID: 2657785
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of septic shock with antibodies to tumour necrosis factor.
    Cohen J; Exley AR
    Schweiz Med Wochenschr; 1993 Mar; 123(11):492-6. PubMed ID: 8475356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sepsis. What it is and how to recognize it.
    Mileski WJ
    Surg Clin North Am; 1991 Aug; 71(4):749-64. PubMed ID: 1862469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell therapy with a tissue-engineered kidney reduces the multiple-organ consequences of septic shock.
    Humes HD; Buffington DA; Lou L; Abrishami S; Wang M; Xia J; Fissell WH
    Crit Care Med; 2003 Oct; 31(10):2421-8. PubMed ID: 14530746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic hemodynamic abnormalities and vasopressor therapy in sepsis and septic shock.
    Quezado ZM; Natanson C
    Am J Kidney Dis; 1992 Sep; 20(3):214-22. PubMed ID: 1519602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.